Holloway Claire M B, Al-Riyees Lolwah, Saskin Refik
Department of Surgical Oncology, Sunnybrook Health Sciences Centre, T2-109 2075 Bayview Avenue, Toronto, ON, M4N 3M5, Canada.
Department of Surgery, King Abdulaziz Medical City, King Fahad Nation Guard Hospital, P.O.Box 22490- MC 1446, Riyadh, 11426, Saudi Arabia.
World J Surg. 2016 Jul;40(7):1590-9. doi: 10.1007/s00268-015-3293-0.
Percutaneous needle biopsy (PNB) is the standard of care for diagnosis of breast lesions. Rates of excisional biopsy for breast diagnosis in North America have been reported at approximately 35 %, although significant regional variation exists. A target rate of PNB for diagnosis of breast abnormalities is needed to facilitate quality improvement. We sought to describe the use of PNB in a referral practice, the clinical scenarios prompting PNB or surgical biopsy (SB), and the accuracy and rate of PNB to inform the ultimate development of a benchmark rate of PNB in breast diagnosis.
Female patients age 18-90 years, referred to Sunnybrook Health Sciences Centre, a large teaching hospital affiliated with the University of Toronto, with a breast lesion prompting tissue diagnosis with SB and/or PNB between 2002 and 2009 were studied. Each biopsied lesion was characterized by method of biopsy: PNB, SB, or PNB followed by SB. For each lesion, we collected data on patient demographics and breast cancer risk, reason for referral, imaging characteristics (breast imaging-reporting and data system classification, full description, final impression before biopsy), and pathology from each biopsy method. We report concordance between the final impression pre-biopsy and the PNB diagnosis with final surgical diagnosis where applicable.
One thousand and twenty-six lesions were biopsied, 987 (96 %) with PNB. The benign:malignant ratio for the entire cohort was 1.2:1. Final impression was concordant with final pathology in 674/862 (78 %) and PNB diagnosis was concordant with SB pathology in 487/556 (88 %). The reasons for SB without PNB were required pathologic evaluation of the entire lesion (n = 19), patient choice (n = 5), other biopsy technique used (n = 6), technical (n = 4), planned mastectomy (n = 3), and enlarging mass (n = 2). 155/559 (28 %) of lesions without evidence of malignancy on PNB ultimately underwent SB. Papillary lesions and radial scars were more likely to undergo SB with or without prior PNB. Lesions deemed to be suspicious or malignant on final impression were more likely to be excised after a benign diagnosis at PNB.
The vast majority of lesions requiring tissue diagnosis can be accurately diagnosed with PNB. Benchmarks for rates of PNB of 90 % or greater may be considered for performance measurement in appropriate populations.
经皮穿刺活检(PNB)是乳腺病变诊断的标准治疗方法。北美地区乳腺诊断的切除活检率据报道约为35%,尽管存在显著的地区差异。需要一个乳腺异常诊断的PNB目标率以促进质量改进。我们试图描述在转诊实践中PNB的使用情况、促使进行PNB或手术活检(SB)的临床情况,以及PNB的准确性和比率,为最终制定乳腺诊断中PNB的基准率提供依据。
对2002年至2009年间转诊至多伦多大学附属大型教学医院桑尼布鲁克健康科学中心、因乳腺病变需要进行组织诊断并接受SB和/或PNB的18至90岁女性患者进行研究。每个活检病变根据活检方法进行分类:PNB、SB或PNB后再行SB。对于每个病变,我们收集了患者人口统计学和乳腺癌风险、转诊原因、影像学特征(乳腺影像报告和数据系统分类、完整描述、活检前最终印象)以及每种活检方法的病理结果。在适用的情况下,我们报告活检前最终印象与PNB诊断以及最终手术诊断之间的一致性。
共对1026个病变进行了活检,其中987个(96%)采用PNB。整个队列的良性与恶性比例为1.2:1。674/862(78%)的最终印象与最终病理结果一致,487/556(88%)的PNB诊断与SB病理结果一致。未进行PNB而直接进行SB的原因包括需要对整个病变进行病理评估(n = 19)、患者选择(n = 5)、使用了其他活检技术(n = 6)、技术原因(n = 4)、计划行乳房切除术(n = 3)以及肿块增大(n = 2)。155/559(28%)在PNB时无恶性证据的病变最终接受了SB。乳头状病变和放射状瘢痕无论是否先前进行过PNB都更有可能接受SB。在最终印象中被认为可疑或恶性的病变在PNB诊断为良性后更有可能被切除。
绝大多数需要组织诊断的病变可以通过PNB准确诊断。对于合适人群的性能评估,可以考虑将90%或更高的PNB率作为基准。